Tanshinone IIA alleviates brain damage in a mouse model of neuromyelitis optica spectrum disorder by inducing neutrophil apoptosis

Tanshinone IIA protects against lipopolysaccharide-induced lung injury through targeting Sirt1

(2019) Minxue Quan et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Sodium tanshinone IIA sulfonate inhibits proliferation, migration, invasion and inflammation in rheumatoid arthritis fibroblast-like synoviocytes

(2019) Zeyu Wang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Sodium Tanshinone II A Sulfonate for Coronary Heart Disease: A Systematic Review of Randomized Controlled Trials

(2018) Mei-li Yu et al.   Chinese Journal of Integrative Medicine

Investigational drugs in development to prevent neuromyelitis optica relapses

(2018) Friedemann Paul et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Novel Anti-Inflammatory Peptides Based on Chemokine–Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis

(2018) Emily F. McNaughton et al.   JOURNAL OF IMMUNOLOGY

Neutrophil Caspase-11 Is Required for Cleavage of Caspase-1 and Secretion of IL-1β in Aspergillus fumigatus Infection

(2018) Yan Sun et al.   JOURNAL OF IMMUNOLOGY

Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage

(2017) Biying Ji et al.   Translational Stroke Research

CFHR1-Modified Neural Stem Cells Ameliorated Brain Injury in a Mouse Model of Neuromyelitis Optica Spectrum Disorders

(2016) Kaibin Shi et al.   JOURNAL OF IMMUNOLOGY

Neurodegeneration in multiple sclerosis and neuromyelitis optica

(2016) Izumi Kawachi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica

(2015) Laura Hertwig et al.   Multiple Sclerosis Journal

Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica

(2015) Laura Hertwig et al.   Multiple Sclerosis Journal

A Zebrafish Compound Screen Reveals Modulation of Neutrophil Reverse Migration as an Anti-Inflammatory Mechanism

(2014) A. L. Robertson et al.   Science Translational Medicine

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions

(2013) Claudia Wrzos et al.   ACTA NEUROPATHOLOGICA

C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica

(2013) Puay-Wah Phuan et al.   ACTA NEUROPATHOLOGICA

Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica

(2013) Julien Ratelade et al.   ACTA NEUROPATHOLOGICA

The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia

(2013) Xin Liu et al.   BIOMATERIALS

Biology of AQP4 and Anti-AQP4 Antibody: Therapeutic Implications for NMO

(2013) A. S. Verkman et al.   BRAIN PATHOLOGY

Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica

(2013) Hua Zhang et al.   JOURNAL OF CLINICAL INVESTIGATION

Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays

(2012) Puay-Wah Phuan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence

(2012) Anu Jacob et al.   Multiple Sclerosis Journal

Anti-Aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica

(2011) Lukmanee Tradtrantip et al.   ANNALS OF NEUROLOGY

Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain

(2011) Samira Saadoun et al.   ANNALS OF NEUROLOGY

Evidence against Cellular Internalizationin Vivoof NMO-IgG, Aquaporin-4, and Excitatory Amino Acid Transporter 2 in Neuromyelitis Optica

(2011) Julien Ratelade et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement

(2011) Samira Saadoun et al.   JOURNAL OF NEUROIMMUNOLOGY

Role of Neutrophil Apoptosis in the Resolution of Inflammation

(2011) Driss El Kebir et al.   TheScientificWorldJOURNAL

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice

(2010) Samira Saadoun et al.   BRAIN

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

(2010) Sven Jarius et al.   Nature Reviews Neurology

Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo

(2009) Monika Bradl et al.   ANNALS OF NEUROLOGY

Intrathecal pathogenic anti–aquaporin-4 antibodies in early neuromyelitis optica

(2009) Jeffrey L. Bennett et al.   ANNALS OF NEUROLOGY

Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies

(2009) Grazia Paola Nicchia et al.   GLIA

Danshen extracts decrease blood c reactive protein and prevent ischemic stroke recurrence: a controlled pilot study

(2009) Gelin Xu et al.   PHYTOTHERAPY RESEARCH

Sulfotanshinone Sodium Injection could decrease fibrinogen level and improve clinical outcomes in patients with unstable angina pectoris

(2008) Fang-fang Yan et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica

(2008) Sven Jarius et al.   Nature clinical practice. Neurology

Constitutive neutrophil apoptosis: Mechanisms and regulation

(2007) Hongbo R. Luo et al.   AMERICAN JOURNAL OF HEMATOLOGY